Elite Pharmaceuticals Inc (ELTP) stock
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –
Elite Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Elite Pharmaceuticals's market cap was $270.10M on Oct 19, 2026, against $657.04M a year earlier. Over the last 5 years it ranged from $30.34M to $782.04M, with a median of $192.64M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $270.10M | -48.7% |
| 2025 | Dec 31, 2025 | $526.23M | -9.0% |
| 2024 | Dec 31, 2024 | $578.04M | +307.2% |
| 2023 | Dec 29, 2023 | $141.95M | +366.7% |
| 2022 | Dec 30, 2022 | $30.42M | +0.3% |
| 2021 | Dec 31, 2021 | $30.34M | -39.9% |
| 2020 | Dec 31, 2020 | $50.46M | -32.7% |
| 2019 | Dec 31, 2019 | $74.96M | +31.1% |
| 2018 | Dec 31, 2018 | $57.18M | -19.2% |
| 2017 | Dec 29, 2017 | $70.74M | -47.2% |
| 2016 | Dec 30, 2016 | $134.04M | -52.0% |
| 2015 | Dec 31, 2015 | $279.11M | +105.1% |
| 2014 | Dec 31, 2014 | $136.08M | +129.2% |
| 2013 | Dec 31, 2013 | $59.37M | +112.2% |
| 2012 | Dec 31, 2012 | $27.97M | +56.8% |
| 2011 | Dec 30, 2011 | $17.83M | – |
See a number that looks wrong?